NeoGenomics
NEO
15.97
-0.54
-3.24%
NeoGenomics
US · NEO
#2660 by market cap
Listed 1970
15.97
-0.54
-3.24%
Live - 5344 symbols - heartbeat 98s ago
· 2026-10-08 08:27
Pre-market
15.52
-2.82%
After-hours
15.97
0.00%
Overnight
16.02
+0.31%
- Market cap
- 2.05B
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on NEO?
Anonymous reader poll. Unscientific, not investment advice.
About NeoGenomics
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
- Founded
- 1998
- CEO
- Mr. Anthony P. Zook
- Employees
- 2,500
- Headquarters
- Fort Myers, Florida, United States of America
- Fiscal year end
- 12-31
- Website
- neogenomics.com
Company profile
- Exchange
- US
- Symbol
- NEO
- Market-cap rank
- #2660
- Listing date
- 1970-01-01
- Market cap
- 2.05B
- Float cap
- 1.87B
- Shares out
- 128.48M
- Float shares
- 117.02M
Sectors & themes
Quote time 2026-10-08 08:27:54 · For reference only, not investment advice and not tailored to your situation.